Home
People
Research
Publications
Links
Contact
Funding
RSS Feed
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Revaz Machaidze
August 30, 2015
«
MALDI Mass Spectrometry Imaging Analysis of Pituitary Adenomas: Toward the Near Real-Time Delineation of Pituitary Tumors.
Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome.
»
News & Events
Craniopharyngioma Trial Continues Enrollment
DRAMATIC CLINICAL RESPONSE TO PD-1 BLOCKADE IN MMR DEFICIENT HIGH-GRADE MENINGIOMA
GERMLINE AND SOMATIC BAP1 MUTATIONS IN HIGH GRADE MENINGIOMA.
HIGHLY MULTIPLEXED IMAGING OF HUMAN TISSUES
Molecular Margins with Metabolite Guide Brain Surgery
PIK3CA MUTATIONS IN MENINGIOMA
TARGETED THERAPY FOR PAPILLARY CRANIOPHARYNGIOMA
Top
